Quarterly Earnings

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

Legal tech firm DISCO reports strong growth fueled by a 600% surge in AI revenue, launching agentic AI and a disruptive new all-in-one pricing model.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

While many cannabis firms struggle, Greenway Greenhouse reports a 40% revenue jump, expanding margins, and its fifth straight quarter of positive EBITDA.

As Kimco Realty prepares to present at the Raymond James conference, investors are watching for insights into its grocery-anchored retail strategy.

With $400M in 2025 sales, Immunocore now leverages its KIMMTRAK success to fund a high-stakes pivot into broader cancers, HIV, and autoimmune disease.

The cold storage giant saw strong cash flow growth in 2025 despite a net loss, but its conservative 2026 forecast signals persistent industry headwinds.

The secure identity firm beat Wall Street estimates with accelerating revenue and record cash flow, signaling major growth and increased shareholder returns.

Fresh off record profits, World Gym details its strategy for global growth, betting on AI health platforms and high-margin services to reshape the industry.

NKT A/S posts record earnings and a €10B backlog, launching a new strategy and major investments to dominate the booming power cable market.

The professional information giant posted robust 2025 earnings while ramping up AI investment and navigating a pivotal CEO transition. Here's what it means.

With its transformative Lanteris acquisition complete, all eyes are on Intuitive Machines' upcoming financial results for clues to its future as a space prime.

The healthcare specialist reported a staggering 2025 net loss due to a write-down, but projects 30% revenue growth fueled by new contracts.

Amid private credit turmoil, SLR Investment Corp. posts solid 2025 results, leveraging a strategic pivot to asset-based lending for stability and returns.

AI marketing firm Zeta Global smashes records for the 18th straight quarter, raising guidance and projecting its first full year of GAAP profitability.

Fueled by policy incentives and strong demand, First Solar reports robust 2025 growth and accelerates its US factory expansion, cementing its market leadership.

Latin American giant MercadoLibre posts record revenue for 2025 but misses profit estimates, sending shares lower as it invests heavily in future growth.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

With 43% YoY growth, Cato Networks is outpacing the SASE market. A new acquisition and key hires signal a deep focus on securing the AI era.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.